Sara Rygol, PA
Physician Assistant · Council Bluffs, IANPI 1184657603
Payments from drug & device makers
Across 470 payments — averaging $22.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- AstraZeneca$916
- Novo Nordisk$718
- Aimmune Therapeutics, Inc.$695
- Pfizer$550
- Lilly USA, LLC$389
- plus $3K from 36 others
What the payments were for
- Consulting fees$2,00019%
- Food & beverage$8,65380%
- Education$1391%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,792 in reported general payments places this provider in the 95th percentile of 1,140 physician assistant providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 99 | $135,891 |
| MounjaroTirzepatide | 89 | $105,733 |
| TrulicityDulaglutide | 91 | $105,204 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 122 | $93,742 |
| EliquisApixaban | 73 | $66,825 |
| JardianceEmpagliflozin | 54 | $57,702 |
| VraylarCariprazine Hcl | 30 | $45,266 |
| XareltoRivaroxaban | 30 | $36,441 |
| MyrbetriqMirabegron | 48 | $34,340 |
| QuliptaAtogepant | 30 | $32,197 |
| RexultiBrexpiprazole | 21 | $31,054 |
| FarxigaDapagliflozin Propanediol | 29 | $29,832 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 43 | $29,009 |
| Tresiba Flextouch U-200Insulin Degludec | 23 | $25,869 |
| Aimovig AutoinjectorErenumab-Aooe | 23 | $18,509 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $389 | $210,937180 claims |
| Novo NordiskOzempic, Rybelsus | $718 | $150,984110 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $162 | $98,459134 claims |
| AbbVieVraylar, Qulipta, Linzess | $4,089 | $93,25175 claims |
| PfizerEliquis, Premarin | $550 | $71,64284 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $916 | $67,652102 claims |
| Boehringer IngelheimJardiance | $126 | $57,70254 claims |
| Johnson & JohnsonXarelto | $126 | $36,44130 claims |
| Astellas Pharma US IncMyrbetriq | $256 | $34,34048 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $255 | $31,05421 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $50 | $16,53821 claims |
| NovartisEntresto | $60 | $10,81013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,140 physician assistant providers in Iowa.
Other physician assistant in Council Bluffs
- Joyce VacekCouncil Bluffs$7K
- Theresa MacdissiCouncil Bluffs$7K
- Amanda LynnCouncil Bluffs$6K
- Holly BaumannCouncil Bluffs$5K
- Quinn SchulteCouncil Bluffs$5K
- Wendy JohnsonCouncil Bluffs$4K
- Jayson GesulgaUrbandale$878K
- Laurie ClairJohnston$293K
- Katherine LemAmes$224K
- Laura CunninghamWest Des Moines$128K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.